Diva Laboratories, Ltd. Statistics
Diva Laboratories, Ltd. (4153) Stock Statistics & Valuation Metrics
Total Valuation
Diva Laboratories, Ltd. has a market cap or net worth of TWD 1.68B. The enterprise value is TWD 1.22B.
- Market Cap
- TWD 1.68B
- Enterprise Value
- TWD 1.22B
Share Statistics
Diva Laboratories, Ltd. has 58,668,198 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 58,668,198
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Diva Laboratories, Ltd.’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.24%.
- Return on Equity (ROE)
- 0.09
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 8.24%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 5.64M
- Profits Per Employee
- 587.92K
- Employee Count
- 154
- Asset Turnover
- 0.64
- Inventory Turnover
- 2.42
Valuation Ratios
The current PE Ratio of Diva Laboratories, Ltd. is 15.95. Diva Laboratories, Ltd.’s PEG ratio is 0.45.
- PE Ratio
- 15.95
- PS Ratio
- 1.92
- PB Ratio
- 1.83
- Price to FCF
- 26.25
- Price to Operating Cash Flow
- 24.36
- PEG Ratio
- 0.45
Income Statement
In the last 12 months, Diva Laboratories, Ltd. had revenue of 868.84M and earned 90.54M in profits. Earnings per share was 1.54.
- Revenue
- 868.84M
- Gross Profit
- 264.68M
- Operating Income
- 102.25M
- Pretax Income
- 108.75M
- Net Income
- 90.54M
- EBITDA
- 112.42M
- Earnings Per Share (EPS)
- 1.54
Cash Flow
In the last 12 months, operating cash flow was 74.97M and capital expenditures -5.79M, giving a free cash flow of 69.18M billion.
- Operating Cash Flow
- 74.97M
- Free Cash Flow
- 69.18M
- Free Cash Flow per Share
- 1.17
Dividends & Yields
Diva Laboratories, Ltd. pays an annual dividend of ―, resulting in a dividend yield of 6.61%
- Dividend Per Share
- ―
- Dividend Yield
- 6.61%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.81%
- Earnings Yield
- 6.30%
Stock Price Statistics
- Beta
- 0.10
- 52-Week Price Change
- -15.03%
- 50-Day Moving Average
- 31.45
- 200-Day Moving Average
- 30.97
- Relative Strength Index (RSI)
- 38.38
- Average Volume (3m)
- 31.72K
Important Dates
Diva Laboratories, Ltd. upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Mar 04, 2027
- Ex-Dividend Date
- ―
Financial Position
Diva Laboratories, Ltd. as a current ratio of 3.35, with Debt / Equity ratio of 0.28%
- Current Ratio
- 3.35
- Quick Ratio
- 2.58
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -4.37
- Interest Coverage Ratio
- 426.06
Taxes
In the past 12 months, Diva Laboratories, Ltd. has paid 18.21M in taxes.
- Income Tax
- 18.21M
- Effective Tax Rate
- 0.17
Enterprise Valuation
Diva Laboratories, Ltd. EV to EBITDA ratio is 10.14, with an EV/FCF ratio of 19.93.
- EV to Sales
- 1.46
- EV to EBITDA
- 10.14
- EV to Free Cash Flow
- 19.93
- EV to Operating Cash Flow
- 18.39
Balance Sheet
Diva Laboratories, Ltd. has TWD 438.10M in cash and marketable securities with TWD 961.00K in debt, giving a net cash position of TWD 437.14M billion.
- Cash & Marketable Securities
- TWD 438.10M
- Total Debt
- TWD 961.00K
- Net Cash
- TWD 437.14M
- Net Cash Per Share
- TWD 7.45
- Tangible Book Value Per Share
- TWD 16.89
Margins
Gross margin is 30.15%, with operating margin of 13.62%, and net profit margin of 12.16%.
- Gross Margin
- 30.15%
- Operating Margin
- 13.62%
- Pretax Margin
- 14.18%
- Net Profit Margin
- 12.16%
- EBITDA Margin
- 14.38%
- EBIT Margin
- 13.60%
Analyst Forecast
The average price target for Diva Laboratories, Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 9.73%
- EPS Growth Forecast
- 36.89%
